Ishita Drugs & Industries Ltd.BSE: ISHITADR

Ishita Drugs & Industries Ltd. Press Release Aug 12 2025

· Issued by Ishita Drugs & Industries Ltd. via BSE India

Filed with BSE · · 7 pages · English

Release

Board of Directors have approved the re-appointment of Mr. Arvind Vilasrao Sapkal (DIN: 08607096) as a non executive independent director for a second term of Five consecutive years, subject to the approval of shareholders of the Company.

Ishita Drugs & Industries Ltd. on 6ix

Earlier from Ishita Drugs & Industries

Later from Ishita Drugs & Industries

All Ishita Drugs & Industries news releases